Cartesian Therapeutics, Inc. — Form D

Cartesian Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-11. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (88)

Showing 25 of 88 people.

NameRoleLocation
Werner CautreelsDirectorWaltham, MA
Omid C FarokhzadDirectorWatertown, MA
Peter Barton HuttDirectorSalt Lake City, UT
Amir Barton NashatDirectorWatertown, MA
Aymeric Barton SallinDirectorWatertown, MA
Timothy Barton SpringerDirectorWatertown, MA
Patrick Barton ZennerDirectorWatertown, MA
David Kei AbrahamExecutive OfficerWatertown, MA
Werner CautreelsExecutive OfficerWaltham, MA
Peter Kei KellerExecutive OfficerWatertown, MA
Earl Kei SandsExecutive OfficerWatertown, MA
David Kei SiewersExecutive OfficerWatertown, MA
CARL GORDONDirectorSAN DIEGO, CA
Timothy A SpringerDirectorWatertown, MA
Chris A JewellExecutive OfficerGaithersburg, MD
Michael C SingerDirectorGaithersburg, MD
Kemal C MalikDirectorGaithersburg, MD
Carsten BrunnDirectorGaithersburg, MD
Carsten BrunnExecutive OfficerGaithersburg, MD
Metin A KurtogluExecutive OfficerGaithersburg, MD
Timothy C BarabeDirectorGaithersburg, MD
Nishan C de SilvaDirectorGaithersburg, MD
Patrick A ZennerDirectorGaithersburg, MD
Emily A EnglishExecutive OfficerGaithersburg, MD
Carrie S CoxDirectorGaithersburg, MD

Other filings by this issuer (15)

FiledFormOfferingSold
2024-07-17D$130.0M$130.0M
2023-12-04D/A$60.3M$60.3M
2023-12-01D$60.3M$60.3M
2020-08-18D$25.0M$25.0M
2020-01-02D$70.0M$70.0M
2019-09-04D$5.8M$5.8M
2016-12-14D$5.0M$5.0M
2015-09-10D$40.6M$37.4M
2015-04-23D$7.5M$5.9M
2014-08-28D$4.5M$4.5M
2014-07-15D$6.0M$6.0M
2014-04-09D$10.0M$5.3M
2011-11-17D$26.0M$3.5M
2011-11-17D$22.0M$22.0M
2010-04-06D$15.0M$15.0M

More